Vanguard Capital Management’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.9M Sell
1,102,925
-13,316
-1% -$101K ﹤0.01% 2962
2026
Q2
$8.77M Buy
1,116,241
+205,501
+23% +$1.45M ﹤0.01% 2901
2026
Q1
$5.01M Buy
+910,740
New +$4.2M ﹤0.01% 3059

Other funds holding DTIL

Vanguard Capital Management's DTIL Position: Q3 2026 in Review

Vanguard Capital Management reduced its Precision BioSciences (DTIL) stake by 1.2% in Q3 2026, selling an estimated $101K and leaving 1,102,925 shares worth $6.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

Vanguard Capital Management first reported a position in DTIL in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.77M in Q2 2026. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

  • Vanguard Capital Management held 1,102,925 shares of Precision BioSciences worth $6.9M as of Q3 2026.
  • Vanguard Capital Management sold 13,316 Precision BioSciences shares in Q3 2026, an estimated $101K.
  • Precision BioSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2962 holding.
  • Vanguard Capital Management first reported a position in Precision BioSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Precision BioSciences position peaked at $8.77M in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.